Androgenetic Alopecia Treatment
Replicel’s hair growth therapy, RCH-01, has officially received approval by Japanese regulatory authorities to be used in a clinical trial that is now launching. We did hear some rumblings recently that Shiseido was putting the final touches on it’s clinical trial to take place at the Tokyo Medical University Hospital and Toho University Ohasi Medical…
Read MoreHello everyone and welcome to a timely edition of Weekly Thoughts. The news involving Kyocera and Dr. Tsuji in this Weekly Thoughts is perhaps the best development I’ve heard of this year since the original buzz of the Brotzu lotion a few months back. This edition also features a new intriguing company that is developing…
Read MoreHey everybody, welcome to another installment of Weekly Thoughts. This week we get an encouraging update about the logistics of Shiseido’s trial and more information about the RiverTown Therapeutics Inc. compound. Shiseido Closer to Trial News was finally released this week about Shiseido’s upcoming trial in Japan using Replicel’s RCH-01 technology. Shiseido acquired an exclusive…
Read More- « Previous
- 1
- 2